about
Systems biology of cisplatin resistance: past, present and futureA new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stressEndoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cellsProtection of cisplatin cytotoxicity by an inactive cyclin-dependent kinase.Akt/mTOR mediated induction of bystander effect signaling in a nucleus independent manner in irradiated human lung adenocarcinoma epithelial cells.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells.Electron microscopy in rat brain slices reveals rapid accumulation of Cisplatin on ribosomes and other cellular components only in gliaInhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells.Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathioneGender differences control the susceptibility to ER stress-induced acute kidney injury.Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin.A Comprehensive Review on the Genetic Regulation of Cisplatin-induced NephrotoxicityCdk2 phosphorylation of Bcl-xL after stress converts it to a pro-apoptotic protein mimicking Bax/Bak.The cell cycle and acute kidney injury.Kinetics of cisplatin binding to short r(GG) containing miRNA mimics - influence of Na(+)versus K(+), temperature and hydrophobicity on reactivity.Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.Overexpression of p18INK⁴C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis.Urinary TIMP2⋅IGFBP7 for the prediction of platinum-induced acute renal injury.Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.Effects of Cisplatin in neuroblastoma rat cells: damage to cellular organelles.Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.Common cytotoxic chemotherapeutics induce epithelial-mesenchymal transition (EMT) downstream of ER stress.Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping.Fluorescent sensing of monofunctional platinum species.Investigation of alternative organic solvents and methods for the preparation of long-circulating and pH-sensitive liposomes containing cisplatin.Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells.Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.Reactivity of kiteplatin with S-donor biomolecules and nucleotidesAn Updated View of Cisplatin Transport
P2860
Q26863585-1E240B4C-E7BE-4C6E-A4E9-AA23BC956E0EQ27014076-487BA3B7-A383-40AA-98DF-144FECE1B585Q28533746-9285234C-0BE8-4BBF-9FC5-403BFAA06FC6Q30495496-41D8535A-6FAC-465C-9EB3-6937C3F4089EQ33566784-3E271D71-7539-4AB1-8533-F59F623C8E4EQ33882297-60C36EC9-FEE7-4E71-9092-F899194DD899Q34540820-78797F56-EE17-4030-9B18-3DD5BDBAAE03Q34919954-8FB41989-F733-4D00-8D44-8CDEFD135F7FQ35728790-1BC3CEF6-D671-45DE-B2F6-5CB2FD35FAEAQ36024718-80E87AEA-B726-4BAB-B20F-673A2260C97AQ36764234-E73114B7-F47E-48F5-AF7E-239BE4241540Q36896039-715A62E1-E0C7-42E9-A98A-004DC27DD2F2Q36906569-675AA78F-CC5A-4491-B6AD-AFE424591BEBQ36927134-FC5005D5-3ED4-4CE4-8EF1-789298B0161BQ37436067-21A25C6E-C0AE-43BD-AD38-533206C0CABFQ38298266-598D86CA-D59E-45FB-AE72-BD0A00F86424Q38754109-40EB0795-40EE-4001-AA67-4B299AD2DA50Q39485992-E7F6A813-BB0A-4321-8F04-6F50D6CCA7C7Q39558420-16322EE6-90B8-48A1-93DE-37C8C8BE651FQ40954510-49FFE0D4-6A16-4EBD-8F12-B8AB0E5D6953Q41736628-82802321-8AC7-4B0F-A625-E8F3BC3D46A5Q41971732-3B57B252-CB76-4232-9904-219EF51088C7Q42129072-CFE361B9-5CBA-4C0F-A598-45156BE09FC0Q42290131-F44DC6E9-3CB5-4B94-8660-4DE924DE94DFQ42949446-4E65DAD7-DCAB-4FA7-B173-A433A2C2F8E7Q46761280-2158870C-0882-4A02-9765-437D836A7BFFQ48010086-3E133B29-A496-4002-9032-7AB4261990F9Q49309271-B97A54FB-82CA-4B1A-88DA-6C4BBC7775E3Q49772000-B5984436-9B0F-4905-A252-AB7FB5F5CF42Q54990021-DDE5D0E0-9F5B-4112-88EE-A9BCE24AB9CFQ59172303-94F7C6A6-172B-49B6-95B6-CF37F5CD127FQ59172334-BB23D792-7B52-4897-8740-4B95A82008DC
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cytoplasmic initiation of cisplatin cytotoxicity.
@ast
Cytoplasmic initiation of cisplatin cytotoxicity.
@en
type
label
Cytoplasmic initiation of cisplatin cytotoxicity.
@ast
Cytoplasmic initiation of cisplatin cytotoxicity.
@en
prefLabel
Cytoplasmic initiation of cisplatin cytotoxicity.
@ast
Cytoplasmic initiation of cisplatin cytotoxicity.
@en
P2093
P2860
P1476
Cytoplasmic initiation of cisplatin cytotoxicity.
@en
P2093
Judit Megyesi
Peter M Price
P2860
P304
P356
10.1152/AJPRENAL.00593.2007
P577
2008-04-09T00:00:00Z